MoneyWorks4Me

Fredun Pharmaceuticals launches cellular longevity dedicated platform ‘Daulcel’

16 May 2026 Evaluate

Fredun Pharmaceuticals has launched ‘DAULCEL’, its premium wellness and longevity-focused brand developed to cater to the growing demand for preventive healthcare, healthy aging, and lifestyle-oriented wellness solutions. The launch marks another strategic step in its expansion into innovation-led and future-focused healthcare segments.

DAULCEL is positioned as a premium wellness platform centered on quality, innovation, and evolving consumer wellness needs. The brand is aimed at addressing the increasing global focus on vitality, wellness optimization, recovery-focused healthcare, and long-term healthy living through science-oriented wellness solutions.

The initiative complements Fredun Pharmaceuticals’ existing pharmaceutical and healthcare capabilities while creating new opportunities within specialized wellness and longevity-driven categories. The launch also reflects the company’s continued focus on building a diversified and future-ready healthcare portfolio

Fredun Pharmaceuticals is engaged in manufacturing of pharmaceutical products.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..